Search research articles
Contact Us
Filters
Showing results (631-640 of 799) with videos related to
Page
of 80
Sort By:
Immunology Letters
|
September 13, 2005
The C3a receptor antagonist SB 290157 has agonist activity
Marie-Claude Mathieu, Nicole Sawyer, Gillian M Greig, et al.
Environmental and Molecular Mutagenesis
|
January 1, 1995
Sensitivity of somatic mutations in human umbilical cord blood to maternal environments
D K Manchester, J A Nicklas, J P O'Neill, et al.
Cancer Research
|
June 30, 2001
Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma
S Sei, D P O'Neill, S K Stewart, et al.
FEBS Letters
|
April 1, 1999
Discovery of a receptor related to the galanin receptors
D K Lee, T Nguyen, G P O'Neill, et al.
Case Reports in Radiology
|
January 6, 2017
Gliosarcoma with Primary Skull Base Invasion
Quoc-Bao D Nguyen, Avital Perry, Christopher S Graffeo, et al.
Toxicology
|
October 28, 1996
hprt mutation frequency among workers exposed to 1,3-butadiene in China
R B Hayes, L Xi, W E Bechtold, et al.
Genes & Development
|
June 4, 2004
The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote
Dirk Schübeler, David M MacAlpine, David Scalzo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 29, 2021
Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention
Brian P O'Neill, Cindy Grines, Jeffrey W Moses, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy
Kelly N H Nudelman, Brenna C McDonald, Yang Wang, et al.
Neuro-Oncology Advances
|
August 15, 2022
Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma
Ian F Parney, S Keith Anderson, Michael P Gustafson, et al.
Page
of 80
Search research articles
Search
Showing results (631-640 of 799) with videos related to
Sort By:
Page
of 80
Immunology Letters
|
September 13, 2005
The C3a receptor antagonist SB 290157 has agonist activity
Marie-Claude Mathieu, Nicole Sawyer, Gillian M Greig, et al.
Environmental and Molecular Mutagenesis
|
January 1, 1995
Sensitivity of somatic mutations in human umbilical cord blood to maternal environments
D K Manchester, J A Nicklas, J P O'Neill, et al.
Cancer Research
|
June 30, 2001
Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma
S Sei, D P O'Neill, S K Stewart, et al.
FEBS Letters
|
April 1, 1999
Discovery of a receptor related to the galanin receptors
D K Lee, T Nguyen, G P O'Neill, et al.
Case Reports in Radiology
|
January 6, 2017
Gliosarcoma with Primary Skull Base Invasion
Quoc-Bao D Nguyen, Avital Perry, Christopher S Graffeo, et al.
Toxicology
|
October 28, 1996
hprt mutation frequency among workers exposed to 1,3-butadiene in China
R B Hayes, L Xi, W E Bechtold, et al.
Genes & Development
|
June 4, 2004
The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote
Dirk Schübeler, David M MacAlpine, David Scalzo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 29, 2021
Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention
Brian P O'Neill, Cindy Grines, Jeffrey W Moses, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy
Kelly N H Nudelman, Brenna C McDonald, Yang Wang, et al.
Neuro-Oncology Advances
|
August 15, 2022
Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma
Ian F Parney, S Keith Anderson, Michael P Gustafson, et al.
Page
of 80